BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31154239)

  • 1. Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs.
    Kamp F; Proebstl L; Hager L; Schreiber A; Riebschläger M; Neumann S; Straif M; Schacht-Jablonowsky M; Manz K; Soyka M; Koller G
    Drug Alcohol Depend; 2019 Aug; 201():8-15. PubMed ID: 31154239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of attentional bias modification training in methamphetamine users receiving residential treatment.
    Dean AC; Nurmi EL; Moeller SJ; Amir N; Rozenman M; Ghahremani DG; Johnson M; Berberyan R; Hellemann G; Zhang Z; London ED
    Psychopharmacology (Berl); 2019 Feb; 236(2):709-721. PubMed ID: 30415277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
    Chen YC; Chen CK; Wang LJ
    J Psychoactive Drugs; 2015; 47(4):317-24. PubMed ID: 26267045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users.
    Northrup TF; Green C; Walker R; Greer TL; Trivedi MH
    Addict Behav; 2015 Mar; 42():144-7. PubMed ID: 25462663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
    Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.
    Manning V; Garfield JBB; Mroz K; Campbell SC; Piercy H; Staiger PK; Lum JAG; Lubman DI; Verdejo-Garcia A
    J Subst Abuse Treat; 2019 Nov; 106():12-18. PubMed ID: 31540606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial.
    Kheirabadi GR; Bahrami M; Shariat A; Tarrahi M
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):45-48. PubMed ID: 33347022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Craving and control: methamphetamine users' narratives.
    Bruehl AM; Lende DH; Schwartz M; Sterk CE; Elifson K
    J Psychoactive Drugs; 2006 Nov; Suppl 3():385-92. PubMed ID: 17357530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users.
    Behle N; Kamp F; Proebstl L; Hager L; Riebschläger M; Schacht-Jablonowsky M; Hamdorf W; Neumann S; Krause D; Manz K; Franke AG; Koller G; Soyka M
    World J Psychiatry; 2022 Jul; 12(7):944-957. PubMed ID: 36051595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between methamphetamine use, psychiatric comorbidities and treatment outcome in two inpatient rehabilitation centers.
    Lisa P; Felicia K; Laura H; Daniela K; Marlies R; Stefanie N; Maik SJ; Anne S; Maximilian S; Kirsi M; Michael S; Gabi K
    Psychiatry Res; 2019 Oct; 280():112505. PubMed ID: 31382181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.
    Hatch-Maillette M; Wells EA; Doyle SR; Brigham GS; Daley D; DiCenzo J; Donovan D; Garrett S; Horigian VE; Jenkins L; Killeen T; Owens M; Perl HI
    J Subst Abuse Treat; 2016 Sep; 68():74-82. PubMed ID: 27431050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment concepts.
    Kamp F; Hager L; Proebstl L; Schreiber A; Riebschläger M; Neumann S; Straif M; Schacht-Jablonowsky M; Falkai P; Pogarell O; Manz K; Soyka M; Koller G
    J Psychiatr Res; 2020 Oct; 129():103-110. PubMed ID: 32652338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bouncing back: Brain rehabilitation amid opioid and stimulant epidemics.
    Stewart JL; May AC; Paulus MP
    Neuroimage Clin; 2019; 24():102068. PubMed ID: 31795056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender does not matter: Add-on repetitive transcranial magnetic stimulation treatment for female methamphetamine dependents.
    Liu T; Li Y; Shen Y; Liu X; Yuan TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():70-75. PubMed ID: 30605708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It's the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use.
    Lee NK; Pohlman S; Baker A; Ferris J; Kay-Lambkin F
    J Subst Abuse Treat; 2010 Apr; 38(3):245-50. PubMed ID: 20116959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.